Immunity-associated with SARS-CoV-2
This 5000 person cohort study examines natural and vaccine-induced immunity to SARS-CoV-2. It aims to answer critical questions about the durability of the immune response as well as repeat infections.
This study is conducted in collaboration with researchers at Michigan Medicine and is funded by the National Institutes of Allergy and Infectious Diseases (NIAID).